Trending in Science
Research on marijuana’s effects led directly to the discovery of a hitherto unknown biochemical communication system in...
Cannabidiol (CBD), a non-psychoactive component of the cannabis plant, has generated significant interest among...
Cannabis terpenes interact synergistically to create what scientists refer to as an “entourage effect” that magnifies...
The Massachusetts-based company Medicinal Genomics has sequenced the entire genome of Cannabis sativa L. The...
Articles in Science
It has been known for some time that CBD acutely increases endogenous cannabinoid levels.
A new wave of research points toward cannabinoids having an adaptive, immunomodulating effect.
Project CBD speaks with neuroscientist Greg Gerdeman on the endocannabinoid system and the biology of wellness
Is cannabis a reproductive toxin? Should products include warning labels? Project CBD responds to call for public comment by California’s Office of Environmental Health Hazard Assessment.
To what extent is research on cannabis in pregnancy complicated by tobacco?
"What about the children?" is a mantra that has been used to propel prohibition with misplaced fear.
Finding an optimal dose is even more difficult for people with liver or kidney diseases, as these are the major organs that clear chemicals from the blood.
A new study from researchers at Yale University suggests that an antipsychotic called haloperidol decreases the psychoactive effects of THC.
Most cannabis supplied by the U.S. government for research has less than 10% THC and it may have been stored for more than a year.
If there’s a gateway, it appears to be early opioid prescriptions, not cannabis.